BeiGene (Germany) Top Insiders
| 49BA Stock | EUR 290.00 2.00 0.68% |
BeiGene employs about 11 K people. The company is managed by 16 executives with a total tenure of roughly 25667 years, averaging almost 1604.0 years of service per executive, having 687.5 employees per reported executive. Examination of BeiGene's management performance can provide insight into the company performance.
| Wang Lai President President Development |
BeiGene |
BeiGene Management Team Effectiveness
The company has return on total asset (ROA) of 0.0169 % which means that it generated a profit of $0.0169 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0181 %, meaning that it generated $0.0181 on every $100 dollars invested by stockholders. BeiGene's management efficiency ratios could be used to measure how well BeiGene manages its routine affairs as well as how well it operates its assets and liabilities. At this time, BeiGene's Non Current Assets Total are most likely to increase significantly in the upcoming years. The BeiGene's current Non Currrent Assets Other is estimated to increase to about 17 M, while Total Assets are projected to decrease to roughly 4.6 B.The current Common Stock Shares Outstanding is estimated to decrease to about 1.2 B. The BeiGene's current Net Loss is estimated to increase to about (1.7 B)BeiGene holds a total of 101.81 Million outstanding shares. 30% of BeiGene outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as BeiGene in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of BeiGene, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
BeiGene Workforce Comparison
BeiGene is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 83,782. BeiGene retains roughly 11,000 in number of employees claiming about 13% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.01 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.12 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.12. BeiGene Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. BeiGene Price Series Summation is a cross summation of BeiGene price series and its benchmark/peer.
BeiGene Notable Stakeholders
A BeiGene stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BeiGene often face trade-offs trying to please all of them. BeiGene's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BeiGene's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| John Oyler | Executive CoFounder | Profile | |
| Wang Lai | President Development | Profile | |
| Chan Lee | General VP | Profile | |
| Titus Ball | VP Officer | Profile | |
| Xiaodong Wang | Chairman CoFounder | Profile | |
| Mi Zhou | Director Relations | Profile | |
| Marcello Damiani | Chief Officer | Profile | |
| Liza Heapes | Head Relations | Profile | |
| Eleanor Duff | Senior Communications | Profile | |
| Kevin Mannix | VP Relations | Profile | |
| Julia Wang | CFO Officer | Profile | |
| Aaron Rosenberg | Chief Officer | Profile | |
| Daniel Maller | VP Accounting | Profile | |
| Diana Francis | VP Compliance | Profile | |
| Xiaobin Wu | COO Pres | Profile | |
| Mark Lanasa | Senior Tumors | Profile |
About BeiGene Management Performance
The success or failure of an entity such as BeiGene often depends on how effective the management is. BeiGene management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BeiGene management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BeiGene management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BeiGene, Ltd., a commercial-stage biotechnology company, develops and commercializes molecularly-targeted and immuno-oncology drugs for the treatment of cancer in the Peoples Republic of China, the United States, and internationally. BeiGene, Ltd. was founded in 2010 and is headquartered in Beijing, the Peoples Republic of China. BEIGENE LTD is traded on Frankfurt Stock Exchange in Germany.
BeiGene Workforce Analysis
Traditionally, organizations such as BeiGene use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BeiGene within its industry.BeiGene Manpower Efficiency
Return on BeiGene Manpower
| Revenue Per Employee | 346.4K | |
| Revenue Per Executive | 238.1M | |
| Net Loss Per Employee | 58.6K | |
| Net Loss Per Executive | 40.3M | |
| Working Capital Per Employee | 161.5K | |
| Working Capital Per Executive | 111M |
Complementary Tools for BeiGene Stock analysis
When running BeiGene's price analysis, check to measure BeiGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeiGene is operating at the current time. Most of BeiGene's value examination focuses on studying past and present price action to predict the probability of BeiGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeiGene's price. Additionally, you may evaluate how the addition of BeiGene to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |